9/25/2014 | CVLM | Lincare to redeem remaining $200,000 of 2.75% convertibles on Nov. 1
|
7/20/2012 | CV | Market Commentary: SanDisk extends hedged gain; Cemex adds outright after earnings; Lincare paper active
|
7/19/2012 | CVLM | Lincare merger to cause fundamental change for 2.75% convertible notes
|
7/6/2012 | CV | Market Commentary: Navistar off on engine news; Lincare gains; Peabody slips; Patriot Coal on tenterhooks
|
7/3/2012 | CV | Market Commentary: Convertibles quiet ahead of holiday; Lincare, Theravance extend gains; U.S. Steel better
|
7/2/2012 | CV | Market Commentary: Lincare jumps on hedged basis on Linde takeout; Amylin up outright on Bristol-Myers deal
|
6/28/2012 | CV | Market Commentary: LifePoint up on health care law ruling; Navistar down; Gevo stock tanks ahead of pricing
|
4/17/2012 | CV | Market Commentary: Tibco Software, Wabash National price at rich end of talk; NetApp trades 'in' slightly
|
7/19/2011 | CV | Market Commentary: Endeavour up on debut; Electronic Arts adds in line; Lincare paper active; Rudolph on tap
|
7/18/2011 | CV | Market Commentary: Convertibles weak; Endeavour sells $120 million deal; WebMD collapses on lowered guidance
|
7/2/2010 | CV | Market Commentary: Convertibles quiet; Lincare A paper improves dollar neutral; Informatica up; Helix firm
|
6/22/2010 | CV | Market Commentary: Teva series Ds active in trade; Transocean ends lower; Biovail, Lincare better; PPL adds
|
2/9/2010 | CV | Market Commentary: Lincare, Alpha Natural add on positive earnings; Waste Connections expands; Annaly prices
|
11/30/2009 | CV | Market Commentary: Convertibles quiet; Transocean active; Lincare gains; Boston Properties adds; Essex quiet
|
10/19/2009 | CV | Market Commentary: Lincare flat to higher, Steel Dynamics steady; GMX Resources, Forest City, Dole to price
|
9/23/2009 | CV | Market Commentary: AMR, Goodrich Petroleum gain on debuts; Gaylord Entertainment, PHH price upsized deals
|
7/20/2009 | CV | Market Commentary: Human Genome surges on lupus trial; Lincare trades before earnings; CIT busy; Intel to price
|
4/21/2008 | CV | Lincare calls 3% convertibles
|
10/31/2007 | CV | Lincare greenshoe fully exercised for series A, B convertibles due 2037
|
10/26/2007 | CV | New Issue: Lincare prices $500 million convertibles in two tranches; both at 2.75%, up 52.5%
|
10/26/2007 | CV | Market Commentary: Countrywide up on positive outlook, helps raise Beazer; Lincare opens strong; Micron active, up
|
10/25/2007 | CV | Lincare prices $500 million convertibles in two tranches; both at 2.75%, up 52.5%
|
10/25/2007 | CV | Market Commentary: NII plummets; Symantec tumbles; Cadence slumps; Henry Schein falls; EMC soars
|
10/24/2007 | CV | Market Commentary: Amazon swings to big loss; YRC active ahead of earnings; Level 3 fall continues; sector woes hurt Intel
|
10/24/2007 | CV | Lincare to offer $500 million convertibles in two tranches; both talked at 2.75%-3.25% coupon, up 50%-55%
|
11/26/2003 | CV | Market Commentary: Nextel Partners gains on S&P outlook; Xerox climbs 3.875 on rosy forecasts; Ciber's issue climbs
|
11/25/2003 | CV | Market Commentary: Ciber popular amid lull in new deals; Ford gains on buying due to better data
|
11/21/2003 | CV | Market Commentary: New paper mixed with thin trading; Lincare, Apria lose on Medicare reform worries
|
11/18/2003 | CV | Market Commentary: AmEx at 100.875 on buying; General Cable bid +3 in gray; Apria gains as stock slammed
|
8/26/2003 | CV | Market Commentary: Mixed bag, as convertibles track stocks in another slow session; Xerox issue soars on dividend
|
6/23/2003 | CV | Lincare greenshoe exercised, raising convertibles to $275 million
|
6/6/2003 | CV | New Issue: Lincare $250 million convertibles yield 3.0%, up 70%
|
6/5/2003 | CV | Lincare $250 million convertibles talked to yield 2.5-3.0%, up 70-75%
|
6/5/2003 | CV | Market Commentary: Continental soars past 107; five new deals totaling $1.23 billion at bat after closing bell
|